Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
943,114
-
Share change
-
+853,574
-
Total reported value
-
$5,818,000
-
Price per share
-
$6.17
-
Number of holders
-
18
-
Value change
-
+$5,267,168
-
Number of buys
-
15
-
Number of sells
-
3
Institutional Holders of Innate Pharma SA - SPONSORED ADS (IPHA) as of Q3 2021
As of 30 Sep 2021,
Innate Pharma SA - SPONSORED ADS (IPHA) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
943,114 shares.
The largest 10 holders included
Balyasny Asset Management LLC, BANK OF AMERICA CORP /DE/, Affinity Asset Advisors, LLC, Virtu Financial LLC, Optiver Holding B.V., PURA VIDA INVESTMENTS, LLC, MILLENNIUM MANAGEMENT LLC, JANE STREET GROUP, LLC, Cubist Systematic Strategies, LLC, and TWO SIGMA INVESTMENTS, LP.
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.